Normally, DNA is transcribed, or copied, to RNA and then translated to protein. Reverse transcriptase copies RNA back to DNA. Think of it as a car moving down a one-way street. Normally traffic only moves in one direction. But then, someone from out of town is driving the opposite way! Reverse transcriptase drives the opposite way in molecular processes in cells, converting RNA back to DNA.
The global market for Reverse Transcriptase was estimated to be worth US$ 321.7 million in 2023 and is forecast to a readjusted size of US$ 419 million by 2030 with a CAGR of 3.8% during the forecast period 2024-2030
Thermo Fisher, Promega, Roche, Bio-Rad and Takara Bio are the main producers of Reverse Transcriptase, the top 3 hold nearly 40% of the whole market. North America is the main market, which holds about 40% of the global marketshare.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Reverse Transcriptase, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Reverse Transcriptase by region & country, by Type, and by Application.
The Reverse Transcriptase market size, estimations, and forecasts are provided in terms of sales volume (L) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Reverse Transcriptase.
Market Segmentation
By Company
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs
Segment by Type:
MMLV Reverse Transcriptase
AMV Reverse Transcriptase
Segment by Application
PCR
Sequencing
Cloning
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Reverse Transcriptase manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Reverse Transcriptase in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Reverse Transcriptase in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Reverse Transcriptase Product Introduction
1.2 Global Reverse Transcriptase Market Size Forecast
1.2.1 Global Reverse Transcriptase Sales Value (2019-2030)
1.2.2 Global Reverse Transcriptase Sales Volume (2019-2030)
1.2.3 Global Reverse Transcriptase Sales Price (2019-2030)
1.3 Reverse Transcriptase Market Trends & Drivers
1.3.1 Reverse Transcriptase Industry Trends
1.3.2 Reverse Transcriptase Market Drivers & Opportunity
1.3.3 Reverse Transcriptase Market Challenges
1.3.4 Reverse Transcriptase Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Reverse Transcriptase Players Revenue Ranking (2023)
2.2 Global Reverse Transcriptase Revenue by Company (2019-2024)
2.3 Global Reverse Transcriptase Players Sales Volume Ranking (2023)
2.4 Global Reverse Transcriptase Sales Volume by Company Players (2019-2024)
2.5 Global Reverse Transcriptase Average Price by Company (2019-2024)
2.6 Key Manufacturers Reverse Transcriptase Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Reverse Transcriptase Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Reverse Transcriptase
2.9 Reverse Transcriptase Market Competitive Analysis
2.9.1 Reverse Transcriptase Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Reverse Transcriptase Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Reverse Transcriptase as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 MMLV Reverse Transcriptase
3.1.2 AMV Reverse Transcriptase
3.2 Global Reverse Transcriptase Sales Value by Type
3.2.1 Global Reverse Transcriptase Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Reverse Transcriptase Sales Value, by Type (2019-2030)
3.2.3 Global Reverse Transcriptase Sales Value, by Type (%) (2019-2030)
3.3 Global Reverse Transcriptase Sales Volume by Type
3.3.1 Global Reverse Transcriptase Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Reverse Transcriptase Sales Volume, by Type (2019-2030)
3.3.3 Global Reverse Transcriptase Sales Volume, by Type (%) (2019-2030)
3.4 Global Reverse Transcriptase Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 PCR
4.1.2 Sequencing
4.1.3 Cloning
4.2 Global Reverse Transcriptase Sales Value by Application
4.2.1 Global Reverse Transcriptase Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Reverse Transcriptase Sales Value, by Application (2019-2030)
4.2.3 Global Reverse Transcriptase Sales Value, by Application (%) (2019-2030)
4.3 Global Reverse Transcriptase Sales Volume by Application
4.3.1 Global Reverse Transcriptase Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Reverse Transcriptase Sales Volume, by Application (2019-2030)
4.3.3 Global Reverse Transcriptase Sales Volume, by Application (%) (2019-2030)
4.4 Global Reverse Transcriptase Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Reverse Transcriptase Sales Value by Region
5.1.1 Global Reverse Transcriptase Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Reverse Transcriptase Sales Value by Region (2019-2024)
5.1.3 Global Reverse Transcriptase Sales Value by Region (2025-2030)
5.1.4 Global Reverse Transcriptase Sales Value by Region (%), (2019-2030)
5.2 Global Reverse Transcriptase Sales Volume by Region
5.2.1 Global Reverse Transcriptase Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Reverse Transcriptase Sales Volume by Region (2019-2024)
5.2.3 Global Reverse Transcriptase Sales Volume by Region (2025-2030)
5.2.4 Global Reverse Transcriptase Sales Volume by Region (%), (2019-2030)
5.3 Global Reverse Transcriptase Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Reverse Transcriptase Sales Value, 2019-2030
5.4.2 North America Reverse Transcriptase Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Reverse Transcriptase Sales Value, 2019-2030
5.5.2 Europe Reverse Transcriptase Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Reverse Transcriptase Sales Value, 2019-2030
5.6.2 Asia Pacific Reverse Transcriptase Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Reverse Transcriptase Sales Value, 2019-2030
5.7.2 South America Reverse Transcriptase Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Reverse Transcriptase Sales Value, 2019-2030
5.8.2 Middle East & Africa Reverse Transcriptase Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Reverse Transcriptase Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Reverse Transcriptase Sales Value
6.2.1 Key Countries/Regions Reverse Transcriptase Sales Value, 2019-2030
6.2.2 Key Countries/Regions Reverse Transcriptase Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Reverse Transcriptase Sales Value, 2019-2030
6.3.2 United States Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Reverse Transcriptase Sales Value, 2019-2030
6.4.2 Europe Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Reverse Transcriptase Sales Value, 2019-2030
6.5.2 China Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.5.3 China Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Reverse Transcriptase Sales Value, 2019-2030
6.6.2 Japan Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Reverse Transcriptase Sales Value, 2019-2030
6.7.2 South Korea Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Reverse Transcriptase Sales Value, 2019-2030
6.8.2 Southeast Asia Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Reverse Transcriptase Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Reverse Transcriptase Sales Value, 2019-2030
6.9.2 India Reverse Transcriptase Sales Value by Type (%), 2023 VS 2030
6.9.3 India Reverse Transcriptase Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Thermo Fisher
7.1.1 Thermo Fisher Company Information
7.1.2 Thermo Fisher Introduction and Business Overview
7.1.3 Thermo Fisher Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Thermo Fisher Reverse Transcriptase Product Offerings
7.1.5 Thermo Fisher Recent Development
7.2 Promega
7.2.1 Promega Company Information
7.2.2 Promega Introduction and Business Overview
7.2.3 Promega Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Promega Reverse Transcriptase Product Offerings
7.2.5 Promega Recent Development
7.3 Roche
7.3.1 Roche Company Information
7.3.2 Roche Introduction and Business Overview
7.3.3 Roche Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Roche Reverse Transcriptase Product Offerings
7.3.5 Roche Recent Development
7.4 Bio-Rad
7.4.1 Bio-Rad Company Information
7.4.2 Bio-Rad Introduction and Business Overview
7.4.3 Bio-Rad Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Bio-Rad Reverse Transcriptase Product Offerings
7.4.5 Bio-Rad Recent Development
7.5 Takara Bio
7.5.1 Takara Bio Company Information
7.5.2 Takara Bio Introduction and Business Overview
7.5.3 Takara Bio Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Takara Bio Reverse Transcriptase Product Offerings
7.5.5 Takara Bio Recent Development
7.6 Agilent
7.6.1 Agilent Company Information
7.6.2 Agilent Introduction and Business Overview
7.6.3 Agilent Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Agilent Reverse Transcriptase Product Offerings
7.6.5 Agilent Recent Development
7.7 Qiagen
7.7.1 Qiagen Company Information
7.7.2 Qiagen Introduction and Business Overview
7.7.3 Qiagen Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Qiagen Reverse Transcriptase Product Offerings
7.7.5 Qiagen Recent Development
7.8 Fapon Biotech
7.8.1 Fapon Biotech Company Information
7.8.2 Fapon Biotech Introduction and Business Overview
7.8.3 Fapon Biotech Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Fapon Biotech Reverse Transcriptase Product Offerings
7.8.5 Fapon Biotech Recent Development
7.9 Toyobo
7.9.1 Toyobo Company Information
7.9.2 Toyobo Introduction and Business Overview
7.9.3 Toyobo Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Toyobo Reverse Transcriptase Product Offerings
7.9.5 Toyobo Recent Development
7.10 Vazyme
7.10.1 Vazyme Company Information
7.10.2 Vazyme Introduction and Business Overview
7.10.3 Vazyme Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Vazyme Reverse Transcriptase Product Offerings
7.10.5 Vazyme Recent Development
7.11 New England Biolabs
7.11.1 New England Biolabs Company Information
7.11.2 New England Biolabs Introduction and Business Overview
7.11.3 New England Biolabs Reverse Transcriptase Sales, Revenue and Gross Margin (2019-2024)
7.11.4 New England Biolabs Reverse Transcriptase Product Offerings
7.11.5 New England Biolabs Recent Development
8 Industry Chain Analysis
8.1 Reverse Transcriptase Industrial Chain
8.2 Reverse Transcriptase Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Reverse Transcriptase Sales Model
8.5.2 Sales Channel
8.5.3 Reverse Transcriptase Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Thermo Fisher
Promega
Roche
Bio-Rad
Takara Bio
Agilent
Qiagen
Fapon Biotech
Toyobo
Vazyme
New England Biolabs
听
听
*If Applicable.